New potent glycogen synthase kinase-3 (GSK-3) inhibitors, 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives, were designed by modeling, synthesized and evaluated in vitro. Compound 17c showed good potency in enzyme and cell-based assays (IC50 = 111 nM, EC50 = 1.78 mu M). Moreover, it has demonstrated desirable water solubility, PK profile, and moderate brain penetration. (c) 2013 Elsevier Ltd. All rights reserved.This study was supported by a Grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A091049-1222-0000300)
Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/th...
AbstractBackground: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine protein kinase, the act...
The glycogen synthase kinase-3 (GSK-3) has been linked to the pathogenesis of colorectal cancer, dia...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
Glycogen synthase kinase 3β (GSK-3β) and casein kinase 1δ (CK-1δ) are emerging targets for the treat...
11 p.-9 fig.-3 tab.Numerous studies have highlighted the implications of the glycogen synthase kinas...
Glycogen Synthase Kinase 3-\u3b2 (GSK-3\u3b2) and Casein Kinase 1-\u3b4 (CK-1\u3b4) are both highly ...
4 p.-4 fig.-1 tab.Glycogen synthase kinase 3 (GSK-3) has become known for its multifactorial involve...
The challenge for glycogen synthase kinase-3 (GSK-3) inhibitor design lies in achieving high selecti...
The challenge for glycogen synthase kinase-3 (GSK-3) inhibitor design lies in achieving high selecti...
For the first time, the in silico design, screening, and in vitro validation of potent GSK-3β type-I...
An in silico screening procedure was performed to select new inhibitors of glycogen synthase kinase ...
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that mediates the addition o...
Direct inhibitors of glycogen synthase kinase 3β (GSK3β) have been investigated and reported for the...
Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/th...
AbstractBackground: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine protein kinase, the act...
The glycogen synthase kinase-3 (GSK-3) has been linked to the pathogenesis of colorectal cancer, dia...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
Compound 5 was selected from our in-house library as a suitable starting point for the rational desi...
Glycogen synthase kinase 3β (GSK-3β) and casein kinase 1δ (CK-1δ) are emerging targets for the treat...
11 p.-9 fig.-3 tab.Numerous studies have highlighted the implications of the glycogen synthase kinas...
Glycogen Synthase Kinase 3-\u3b2 (GSK-3\u3b2) and Casein Kinase 1-\u3b4 (CK-1\u3b4) are both highly ...
4 p.-4 fig.-1 tab.Glycogen synthase kinase 3 (GSK-3) has become known for its multifactorial involve...
The challenge for glycogen synthase kinase-3 (GSK-3) inhibitor design lies in achieving high selecti...
The challenge for glycogen synthase kinase-3 (GSK-3) inhibitor design lies in achieving high selecti...
For the first time, the in silico design, screening, and in vitro validation of potent GSK-3β type-I...
An in silico screening procedure was performed to select new inhibitors of glycogen synthase kinase ...
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that mediates the addition o...
Direct inhibitors of glycogen synthase kinase 3β (GSK3β) have been investigated and reported for the...
Glycogen synthase kinase-3β, also called tau phosphorylating kinase, is a proline-directed serine/th...
AbstractBackground: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine protein kinase, the act...
The glycogen synthase kinase-3 (GSK-3) has been linked to the pathogenesis of colorectal cancer, dia...